Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia

CompletedOBSERVATIONAL
Enrollment

618

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

May 9, 2017

Study Completion Date

January 18, 2018

Conditions
Myocardial Ischemia
Trial Locations (18)

29425

Medical University of South Carolina, Charleston

30606

Oconee Heart and Vascular Center at St Mary's Hospital, Athens

35801

Heart Center Research, LLC, Huntsville

36608

Mobile Cardiology Associates, Mobile

64111

St. Luke's Lipid and Diabetes Research Center, Kansas City

75069

Cardiac Center of Texas, McKinney

77030

Houston Methodist Hospital, Houston

89502

Renown Heart and Vascular, Reno

95119

Kaiser Permanente Hospital, San Jose

98372

Multicare HS Institute for Research & Innovation, Tacoma

Unknown

Providence Health Care- St. Paul's Hospital; University of British Columbia, Vancouver

State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing

Centro Cardiologico Monzino, IRCCS and University of Milan, Milan

Fondazione Toscana Gabriele Monasterio, Pisa

St. Luke's Hospital, Tokyo

Paul Stradins University Hospital, Riga

VU University Medical Center, Amsterdam

Severance Cardiovascular Hospital, Seoul

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Weill Medical College of Cornell University

OTHER

NCT02173275 - Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia | Biotech Hunter | Biotech Hunter